Jojo2019, I already posted to you 2/3 days mentioning the rns where licensing with volz is CLEARLY mentioned (not the word itself) yet you laughed it off and carry on dismissing in your post today. Here is the quote from the rns of 16 November.
“Over the weekend P2F signed binding heads of terms with a manufacturer of surgical masks in Germany. The German manufacturer will subcontract to supply complete masks to P2F to the P2F specification and brand name, and also purchase P2F filter material for their own brand masks. Under the heads of terms the manufacturer will also develop and supply anti-viral C-Fold masks using P2F filter material to extend P2F's market reach. The heads of terms are subject to final contractual agreement between the parties.”
16 November
https://www.lse.co.uk/rns/RMS/pharm-2-farm-update-5j5o9badil6wakn.html
Incidentally Jojo2019, what do we call some who laugh at others when they get the wrong end of the stick themselves? And where should that stick be put?
Continued from below
With the addition of Professors Stebbing and Garner, Block Commodities' management is confident that it has assembled a world-class team of experts in evaluation and development of medicines and the application of cannabis for health and wellness. Block Commodities aims to be a market leader in CBD research and cultivation, as well as a manufacturer of efficacious products of the highest consistency and quality.
Ian Tordoff, Chief Executive Officer of Block Commodities commented: "Following the Company's General Meeting on 27 December 2019, the shareholders approved a new investment strategy to operate in the medicinal cannabis, CBD wellness and hemp sectors. I am delighted to welcome Professor Stebbing and Professor Garner to our Scientific Advisory Team to develop and drive Block's ambitions in these markets. We aim to create OTC products for consumers who want access to the highest quality CBD products appropriate to their circumstances. The SAT is essential to the business in the shaping of research and product development, which underpin our commercial goals. We are all looking forward to working closely together in the coming months.
ENDS
Block Commodities strengthens its Scientific Advisory Team ("SAT") with two key appointments
London, 9 January 2020 - Block Commodities Ltd today announces the appointments of Professor Justin Stebbing and Professor Andrew Garner to its Scientific Advisory Team (SAT). Professor Stebbing joins the SAT as Chair and will play a central role in helping the Board to identify and unlock suitable investment opportunities in the CBD wellness and medicinal cannabis market. The SAT is further strengthened by the appointment of Professor Andy Garner, who joins as a highly respected pharmaceutical and medical research expert. Together with the existing members, Dr. Frank Ambrosio and Dr. Olusola Idowu, the SAT is working with partners to develop pilot studies to establish the efficacy of proprietary compounds treating a number of conditions.
Professor Stebbing is a Professor of Cancer Medicine and Oncology and Consultant Oncologist at Imperial College London, specialising in the treatment of cancer by immunotherapy. Professor Stebbing brings to the position relevant board experience from his current roles as Chair of the World Vaccine Congress and the Irish Cancer Society oversight committee. He is a Fellow of the Royal College of Physicians, the American Board of Internal Medicine and the Royal College of Pathologists. Furthermore, he is a published author of world leading medicine and cancer journals, such as The Journal of Clinical Oncology and The Lancet Oncology. He was awarded the Silvia Lawler prize for excellence in oncology in 2015 and has extensive clinical practice experience, including translational research studies and immunotherapy trials, most recently undertaking biosimilar studies. In 2016, he was internationally recognised with his appointment as Editor-in-Chief of Oncogene (Springer Nature's foremost cancer journal) and election to the American Society for Clinical Investigation.
Professor Andrew Garner has held senior positions at universities in the United Kingdom, Europe, USA and the Middle East, as well as executive posts in the National Health Service and the pharmaceutical industry. In 2007, he was appointed as Dean and PVC at Keele University to develop and lead the Faculty of Medicine & Health Sciences including new schools of Medicine and Pharmacy together with Research Institutes focused on Primary Care, Secondary Care and Laboratory Medicine. As a pharmacologist, he joins the SAT with extensive research and consultancy experience in drug development including 9 years as Company Senior Scientist with AstraZeneca. He was previously NHS R&D Director for Greater Manchester, Head of Manchester Medical School and a member of the Boards of the University Hospital of North Midlands and West Midlands Academic Health Science Networt.
To be continued
Including one from Imperial College and another world renown one. Surely such high caliber scientists see value in blcc. Anyone knows of any progress so far? Cheers
HL are showing sell higher than buy, 0.003 vs 0.0028, and 0 money in my account on the stock lol. Yet they’re supposed to be the biggest broker...go figure.
Incidentally I message them yesterday to request they put the stock for online trading as opposed to telephone only at the moment. I suggest others do like wise. I’ve heard the more request they get, they are likely to oblige. You can trade kr1 online but on kill/full basis, still better and you get live price.
Josepi, I wouldn’t trust west vaccine- 1 instead of the 10 years it normally take for vaccine development. Plus why did the west vaccine manufacturers seek and get immunity (no pun intended) from prosecution or damages payments?
Lockedandloaded, it was completed last August or October can’t recall exactly. Jarvy55 posted a video of it on here, think it was YouTube. Hope that helps.
India, China and Russia have vaccinated only 5% of their population so far. Most Russian don’t trust the vaccine because conspiracy theories.
According to the guardian yesterday.
I think because it’s on Aquis exchange as oppose to aim and so it’s under the radar- good for getting in/topping up before the herd which is just a matter of time; see kr1 on the same exchange for example, from 25p to over 200p in 2 months.
Block Commodities Ltd: Cannabis Seed Stock - Option Agreement
24-March-2021 / 07:00 GMT/BST
Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
24 March 2021
BLOCK COMMODITIES LIMITED
("Block Commodities", "BLCC" or the "Company")
Cannabis Seed Stock - Option Agreement
Block Commodities is pleased to announce that the Company and Century Cobalt Corporation ("CCOB"), together the "Acquiring Parties", have entered into an option agreement to acquire approximately 2 million seeds from a private seed bank based in Cleveland, Ohio. CCOB is a publicly traded (OTCQB: CCOB) cobalt exploration and development company headquartered in Los Angeles, California.
The seeds comprise 4 varietals suitable for the production of medicinal grade cannabis, with an average 14.5% Cannabinoid content and a 0.25% THC content. If the Option is exercised, each of BCL and CCOB will hold an interest of 50% in the cannabis seed stock.
The option is for an exclusivity period of 90 days to complete due diligence and the purchase. The proposed terms of the purchase are as follows:
Payment of an Option fee of £2, to be apportioned equally between the Acquiring Parties, and
Payment by BLCC of GBP 100,000 through the issue of 142,857,143 fully paid ordinary shares in BLCC (calculated at 0.07p per share) upon exercise of the option, and contemporaneously the payment by CCOB of GBP100,000 of CCOB fully paid ordinary shares in CCOB at US Cents 7 per share (using the US$:GB£ closing middle market exchange rate published by the Bloomberg on the day immediately prior to completion).
The Directors of the Company accept responsibility for the content of this announcement.
For further information, please contact:
Block Commodities Limited
Ian Tordoff
nc@blockcommodities.com
Aquis Exchange Corporate Adviser:
First Sentinel Corporate Finance Limited
+44 7876 888 011
Brian Stockbridge
Gabrielle Cordeiro
ISIN: GG00B4QYTJ50
Category Code: ACQ
TIDM: BLCC
LEI Code: 2138001KNTXRAZTFKU51
Sequence No.: 96101
EQS News ID: 1177765
NMDC44, most buys are shown as sells, just like other investors inc my self have said the same. Weird!!!
Great news!!! Will we see a rerate like other cannabis stocks. You bet
Therefore P2F should be like a broken ATM machine dishing cash nonstop with a tube linked to the Bank of England making the ‘rot’child a pauper by comparison, lol. Open a sipp and prepare to retire early I’d say and then you should able to afford a house under the sea to escape the next pandemic, yes living among the fish inc sharks will be a lot safer than with your loved ones, by the look of how we’ve messed up Mother Earth.
Are we getting an rns today .....or rms?
Governments will have to stockpile masks indefinitely...”we need to prepare”,
By the same scientist who predicted this pandemic only 5 years ago.
‘As the author of a 2016 book called The Next Plague, he says it is only a matter of time until the next pandemic. “The risks are very high. It’s just a case of when and where. We need to prepare.”’
https://www.theguardian.com/environment/2021/mar/24/disease-outbreaks-more-likely-in-deforestation-areas-study-finds
Jojo, the mask kills the virus 100% although p2f says 99% cause it’s a standard by all Pharma companies to claim less to avoid unnecessary messy legal disputes. Google it.
MrMerlot, sorry for the late reply. the rns on 4 March stresses the fact rms wants to concentrate on developing other p2f products and leave masks production to the likes of volz. Also as per previous rns we have 2 potential contracts with volz, one to produce for us and the other production of their own mask using our tech which can only be through licence. Sorry I didn’t make that clear, I assumed people were up to date with previous updates re volz.
berl , Is the 30,151,515 yours showing as sell? Mine of just under 10,000,000 this morning showed as sell too. Wonder how many are in a similar situation.
Nina007, re Bocking Arts Theatre, goes to show our mask is reaching other business sectors in this case the entertainment industry, building momentum as someone said.
Ptin, exactly! I forgot to add rms maybe going for smaller sellers now because our machines not in full production. I’d rather they did this and get the mask out as quickly as possible so it becomes public knowledge while continue to negotiate big deals with the likes of volz and maybe others too.
SOUSAV, if each of the small sellers already selling ordered 1 million mask a month and we have 4/5 so far, that’s 60 millions a year. Without other businesses ordering and volz and other big manufacturers licensing. Every little thing helps, or look at the pennies the £ will look after themselves. It’s a unique product in a global demand, multiply these small sellers in several countries.